← Back to Search

Diabetes Telemonitoring for Type 2 Diabetes

N/A
Waitlist Available
Led By Renee Pekmezaris, PhD
Research Sponsored by Northwell Health
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 months
Awards & highlights

Study Summary

This trialcompares two ways of managing diabetes to see which is most effective at improving patient health.

Eligible Conditions
  • Type 2 Diabetes

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Hemoglobin A1C
Secondary outcome measures
Adherence
Blood Pressure
Cholesterol
+6 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Diabetes Telemonitoring (DTM)Experimental Treatment1 Intervention
Diabetes Telehealth Management (DTM), based on the 2018 ADA Standards for Type 2 Diabetes (T2D), uses smart devices to share information between patients, caregivers, and clinicians. DTM includes:1) weekly real time "virtual" visit between patient and clinician 2) vital signs monitoring/interpretation 3) diabetes management 4) patient interactive educational videos and "teach back" quizzes, reinforcing self-management strategies 5) a caregiver app with supportive capability.
Group II: Comprehensive Outpatient Management (COM)Active Control1 Intervention
Comprehensive Outpatient Management (COM) is the most realistic evidence-based comparator, in that it is the most frequently recommended and used option for US T2D patients. COM, like DTM, is consistent with the 2018 American Diabetes Association (ADA) Standards which include, but are not limited to, past medical and family history, social history, medications, screening, physical examination, laboratory evaluation, etc.Patients are instructed to monitor blood glucose (within physician recommendations), and have routine or "well" visits every 3 months. Patients can set appointments with a T2D educator. COM patients will receive monthly calls from the study Registered Nurse (RN) to collect data.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Diabetes Telemonitoring
2019
N/A
~240

Find a Location

Who is running the clinical trial?

Patient-Centered Outcomes Research InstituteOTHER
548 Previous Clinical Trials
29,996,347 Total Patients Enrolled
Northwell HealthLead Sponsor
456 Previous Clinical Trials
469,947 Total Patients Enrolled
Renee Pekmezaris, PhDPrincipal InvestigatorFeinstein Institute for Medical Research
2 Previous Clinical Trials
123 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does this research still have open enrollment for participants?

"According to clinicaltrials.gov, this medical trial has stopped recruiting participants as of October 31st 2022. Initially posted on September 30th 2019, it is one of the 1441 other studies currently looking for volunteers."

Answered by AI
~44 spots leftby Mar 2025